Health Care & Life Sciences » Pharmaceuticals | Zomedica Pharmaceuticals Corp.

Zomedica Pharmaceuticals Corp. | Balance Sheet

Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
Cash & Short Term Investments
81.60
230.80
178.90
111.30
Total Accounts Receivable
-
4.60
2.60
-
Other Current Assets
-
-
-
-
Total Current Assets
81.60
235.40
181.50
111.30
Net Property, Plant & Equipment
-
-
-
-
Intangible Assets
-
-
-
-
Other Assets
18.00
-
-
-
Total Assets
99.60
235.40
181.50
111.30
Accounts Payable
-
5.70
-
-
Other Current Liabilities
1.00
-
4.90
8.60
Total Current Liabilities
1.00
5.70
4.90
8.60
Total Liabilities
1.00
5.70
4.90
8.60
Common Equity (Total)
98.60
229.60
176.60
102.70
Total Shareholders' Equity
98.60
229.60
176.60
102.70
Total Equity
98.60
229.60
176.60
102.70
Liabilities & Shareholders' Equity
99.60
235.40
181.50
111.30

About Zomedica Pharmaceuticals

View Profile
Address
100 Phoenix Drive
Ann Arbor Michigan 48108
United States
Employees -
Website http://www.zomedica.com
Updated 07/08/2019
Zomedica Pharmaceuticals Corp. is a pharmaceutical company, which targets health and wellness solutions for the companion pet (canine, feline and equine) through a ground-breaking approach that focuses on the needs of the veterinarians. Its building a diversified portfolio of products comprised of the discovery, development and commercialization of innovative drugs alongside novel drug delivery systems, devices and diagnostics. The company was founded on May 14, 2015 and is headquartered in Ann Arbor, MI.